GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MMP2, NR3C1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR |
13.8553 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR |
12.3207 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, HSD17B2, HSP90AB1, IDO1, IGF1R, MMP2, MMP9, NR3C1, PPARG, PRKCB, PRKCD, PRKCE, RORC, SRC, TYR |
11.5588 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, ALPL, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR, XDH |
10.7714 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, ALPL, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR, XDH |
10.2323 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, IDO1, NR3C1, PPARG, PRKCE, RORC, SRC, TYR |
10.2323 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
9.25674 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, HSP90AB1, NR3C1, PPARG, PRKCE, PRKCG, RORC, SRC, TYR |
9.13261 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AR, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, PRKCB, PRKCD, PRKCE, RORC, SRC |
8.51475 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AR, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, NR3C1, PPARG, PRKCB, PRKCD, PRKCE, RORC, SRC |
8.33726 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
8.11866 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, FABP3, FLT3, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
7.24492 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARG, RORC, SRC |
7.11469 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
7.10446 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, NR3C1, PPARG, PRKCD, PRKCE, SRC |
6.7883 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX15, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, KDR, MET, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
6.75904 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARG, PRKCA, PRKCD, PRKCG, SRC, XDH |
6.75904 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FABP3, FABP4, HSD11B1, HSD17B1, HSD17B2, MET, PPARG |
6.73711 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PIM1, PPARG, TYR, XDH |
6.67429 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX15, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
6.54449 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, IGF1R, MMP2, NR3C1, PPARG, PRKCD, PRKCE, SRC |
6.3576 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARG, RORC, SRC |
6.32371 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARG, PRKCA, PRKCD, PRKCG, SRC, XDH |
6.27057 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, PRKCD, PRKCG, SRC |
6.2439 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, PRKCB, PRKCD, PRKCE, RORC, SRC |
6.24063 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, PIM1, PPARG, RORC, SRC |
6.1974 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AR, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, NR3C1, PPARG, PRKCB, PRKCD, PRKCE, RORC, SRC |
6.16499 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD11B1, HSD17B1, HSD17B2 |
6.16187 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, HSP90AB1, IDO1, IGF1R, KDR, MMP9, PIM1, PPARG, PRKCA, PRKCD, PRKCG, SRC, XDH |
6.1373 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD17B1, HSD17B2, IDO1, PPARG, TYR, XDH |
6.11183 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 |
6.03214 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALOX15, ALPL, AR, AURKB, AXL, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR |
5.93436 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.93436 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, AR, CYP1A1, CYP1B1, ESR1, FLT3, HSP90AB1, NR3C1, PPARG, RORC, SRC |
5.92301 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, ALPL, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR, XDH |
5.91514 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PRKCA, PRKCD, PRKCG, SRC |
5.80318 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PRKCD, SRC |
5.78737 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, HSP90AB1, KDR, MET, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
5.58984 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, CSNK2A1, HSP90AB1, IDO1, IGF1R, KDR, MMP9, PIM1, PRKCA, PRKCD, PRKCG, SRC |
5.57238 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, HSP90AB1, KDR, MET, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
5.57238 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.55973 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.51302 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, FABP3, HSP90AB1, KDR, NR3C1, PPARG, PRKCD, PRKCE, PRKCG, SRC |
5.51018 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, PPARG, SRC, TYR |
5.39772 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARG, RORC |
5.36103 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.32624 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.21791 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, ALPL, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR, XDH |
5.18472 |
[BP] GO:0030168 |
platelet activation
|
AXL, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.17428 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.12062 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, AR, AXL, CSNK2A1, CYP1B1, FABP4, FLT3, HSP90AA1, HSP90AB1, IDO1, KDR, MET, MMP2, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, XDH |
5.10657 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1, PPARG, PRKCE, SRC |
5.04633 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PRKCD, SRC |
4.91434 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PRKCD, SRC |
4.86579 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, PRKCG, SRC |
4.7488 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, AR, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, MET, MMP2, MMP9, PGR, PIM1, PPARG, PRKCA, PRKCD, RORC, SRC, TYR |
4.70648 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
4.70185 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, HSP90AB1, KDR, NR3C1, PRKCD, PRKCE, SRC |
4.70185 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.66409 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARG, RORC |
4.63351 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, NR3C1, PPARG, PRKCE, SRC |
4.62505 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARG |
4.54691 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2, PRKCA, PRKCE |
4.51239 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, HSP90AA1, KDR, PRKCD, PRKCE, SRC |
4.47624 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, FABP3, PPARG |
4.32857 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
4.31123 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
4.31059 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, AR, CSNK2A1, CYP1B1, ESR1, FABP3, FLT3, IDO1, IGF1R, KDR, MMP2, MMP9, PGR, PIM1, PPARG, PRKCA, SRC, XDH |
4.28791 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.28361 |
[BP] GO:0051972 |
regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
4.2809 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
4.22527 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.13561 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, HSD11B1, HSD17B2, HSP90AB1, KDR, MMP9, PGR, PIM1, PPARG, RORC, SRC, TYR |
4.12013 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.12013 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.09776 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, AR, AXL, CSNK2A1, CYP1B1, FLT3, HSP90AB1, KDR, MET, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
4.0578 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, PRKCD, SRC |
3.95836 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.95836 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, MET, PPARG, PRKCB, PRKCE, SRC |
3.957 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, ESR1, FLT3, NR3C1, PPARG, PRKCE, RORC, SRC |
3.957 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX15, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FABP4, FLT3, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP2, MMP9, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, XDH |
3.95487 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, XDH |
3.8762 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.8762 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.8762 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PPARG |
3.8762 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.86474 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, HSP90AB1, RORC |
3.86101 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
3.85805 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, HSP90AB1, PPARG, SRC |
3.8578 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARG, PRKCD, PRKCE, PRKCG, SRC, TYR |
3.77797 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
3.75799 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, SRC |
3.75386 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, PRKCA, PRKCB, PRKCD |
3.74965 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, PGR, PPARG, PRKCG, RORC, SRC |
3.72022 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARG, PRKCD, PRKCE, SRC |
3.70842 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX15, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FABP3, FABP4, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
3.70256 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, AR, AURKB, CSNK2A1, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
3.6974 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, SRC |
3.67713 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, XDH |
3.64765 |
[BP] GO:0080134 |
regulation of response to stress
|
CYP19A1, ESR1, FABP4, HSP90AA1, HSP90AB1, IDO1, IGF1R, MET, MMP2, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, SRC, XDH |
3.63188 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, MET, PIM1, PRKCD, SRC, TYR |
3.60357 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, FLT3, HSP90AA1, HSP90AB1, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC |
3.56424 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, MET, PPARG |
3.54229 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, HSP90AA1, HSP90AB1, IGF1R, PRKCD, PRKCG, SRC |
3.50567 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AR, AXL, CYP1B1, FLT3, KDR, MET, PRKCA, PRKCB, PRKCE, SRC, XDH |
3.48897 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARG, PRKCD, PRKCE, PRKCG, SRC, TYR |
3.48773 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PPARG, PRKCA, PRKCE, SRC |
3.48773 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FABP3, FABP4, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
3.47543 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, FABP3, PPARG |
3.47219 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, AR, AURKB, CSNK2A1, ESR1, ESR2, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
3.46572 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, AR, AURKB, ESR1, ESR2, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
3.46572 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AR, ESR1, FLT3, IGF1R, MMP2, NR3C1, PPARG, PRKCD, PRKCE, SRC |
3.46572 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.46423 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, AR, AURKB, CSNK2A1, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
3.43483 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARG, PRKCA, PRKCD, PRKCE, SRC |
3.42395 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AR, AURKB, AXL, ESR1, IGF1R, KDR, MET, MMP1, MMP9, PPARG, PRKCD, PRKCE, SRC |
3.40502 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PPARG, PRKCE, SRC |
3.4008 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AR, AXL, CYP19A1, CYP1A1, ESR1, HSD17B2, HSP90AB1, IDO1, MMP2, MMP9, PGR, PPARG, SRC |
3.38723 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.34864 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PIM1, PPARG, TYR |
3.33694 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ALOX15, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
3.32744 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AR, ESR1, FLT3, NR3C1, PPARG, PRKCD, PRKCE, SRC |
3.22217 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, CYP19A1, ESR1, HSD17B2, HSP90AB1, PGR, PPARG, SRC |
3.15892 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.13482 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
3.13482 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX15, ALOX5, ALPL, AR, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, FABP4, HSD17B2, IDO1, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PRKCD, PRKCG, RORC, SRC, TYR |
3.13365 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, HSP90AA1, IDO1, MMP1, MMP2, MMP9, SRC, XDH |
3.11977 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
3.11211 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, FABP3, FLT3, PPARG, PRKCD, PRKCE, RORC, SRC |
3.05944 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
3.04339 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
3.03486 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, PRKCD, SRC |
2.98011 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, AR, AXL, CA1, CA2, CSNK2A1, CYP1B1, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC |
2.96561 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PIM1, PPARG, TYR |
2.95599 |
[BP] GO:2000278 |
regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
2.90027 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.89354 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, IDO1, PIM1, PPARG, TYR |
2.89354 |
[BP] GO:0051052 |
regulation of DNA metabolic process
|
AURKB, HSP90AA1, HSP90AB1, IGF1R, PPARG, PRKCD, PRKCG, SRC |
2.89354 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, ESR2, FLT3, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, SRC, XDH |
2.88 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD, SRC |
2.8563 |
[BP] GO:0043254 |
regulation of protein complex assembly
|
ALOX15, ESR1, HSP90AA1, MET, MMP1, PRKCD, PRKCE, SRC |
2.85412 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, AXL, CA2, CYP19A1, ESR1, HSP90AA1, HSP90AB1, IDO1, MMP2, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, SRC |
2.85195 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, SRC |
2.78888 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, PRKCD, SRC |
2.75599 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, CA2, CYP1A1, HSP90AA1, HSP90AB1, MMP2, PPARG, PRKCB, PRKCE, SRC, TYR |
2.74855 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
AR, AURKB, CSNK2A1, ESR1, ESR2, FABP4, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
2.69935 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2 |
2.66799 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, ESR1, ESR2, FABP3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NR3C1, PGR, PPARG, PRKCD, RORC, SRC |
2.63114 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, HSP90AB1, MET, MMP9, PRKCD, SRC |
2.63114 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.62922 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.62922 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD |
2.58946 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, AR, FLT3, IGF1R, KDR, PRKCA, PRKCD, PRKCE, SRC, XDH |
2.57884 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
2.56997 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CSNK2A1, ESR1, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, PRKCA |
2.55181 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, SRC |
2.52027 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.52027 |
[BP] GO:0038096 |
Fc-gamma receptor signaling pathway involved in phagocytosis
|
HSP90AA1, HSP90AB1, PRKCD, PRKCE, SRC |
2.51854 |
[BP] GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis
|
HSP90AA1, HSP90AB1, PRKCD, PRKCE, SRC |
2.51854 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, CA2, FLT3, NR3C1, SRC |
2.5 |
[BP] GO:0002431 |
Fc receptor mediated stimulatory signaling pathway
|
HSP90AA1, HSP90AB1, PRKCD, PRKCE, SRC |
2.49443 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.47587 |
[BP] GO:0038094 |
Fc-gamma receptor signaling pathway
|
HSP90AA1, HSP90AB1, PRKCD, PRKCE, SRC |
2.46939 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, AR, AURKB, AXL, CSNK2A1, ESR1, ESR2, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP9, PPARG, PRKCD, PRKCE, PRKCG, SRC |
2.46939 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, MET, MMP1, PRKCE, SRC |
2.44956 |
[BP] GO:0035902 |
response to immobilization stress
|
CYP1A1, CYP1A2, PPARG |
2.42997 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.42997 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AR, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, ESR1, FLT3, HSP90AA1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TYR, XDH |
2.41779 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, AR, FABP3, FLT3, HSP90AB1, KDR, MMP9, PRKCA, PRKCD, PRKCE, SRC, XDH |
2.4112 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, AR, FABP3, FLT3, HSP90AB1, KDR, MMP9, PRKCA, PRKCD, PRKCE, SRC, XDH |
2.4112 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, HSP90AB1, MET, MMP9, PPARG, PRKCD, SRC |
2.38798 |
[BP] GO:1905323 |
None
|
HSP90AA1, HSP90AB1 |
2.38798 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.38798 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.38798 |
[BP] GO:0030334 |
regulation of cell migration
|
CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCE, SRC |
2.36684 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.36684 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, HSP90AA1, KDR, SRC |
2.36684 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, ESR1, FABP3, FABP4, MET, PPARG, PRKCB, PRKCE |
2.34818 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, AR, FLT3, HSP90AB1, KDR, MMP9, PRKCA, PRKCD, PRKCE, SRC, XDH |
2.34393 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AR, AURKB, ESR1, ESR2, HSP90AA1, HSP90AB1, IGF1R, MET, NR3C1, PGR, PPARG, PRKCD, PRKCG, RORC, SRC |
2.34393 |
[BP] GO:0009410 |
None
|
HSP90AB1, NR3C1, PPARG, PRKCE, PRKCG |
2.33052 |
[BP] GO:0071383 |
None
|
AR, FLT3, NR3C1, SRC |
2.33045 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, ESR1, FABP4, IDO1, KDR, MET, PPARG, PRKCA, PRKCD, PRKCG |
2.3282 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, KDR, MET, MMP1, PRKCA, PRKCE, SRC |
2.31764 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, ESR1, FABP4, HSP90AB1, IDO1, MMP2, PPARG, PRKCD, PRKCE, SRC |
2.31764 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.31764 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AR, AURKB, CSNK2A1, ESR1, ESR2, FABP4, HSP90AB1, IGF1R, MET, MMP9, NR3C1, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
2.30687 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, FLT3, PPARG |
2.30187 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AR, AXL, CA2, CYP1B1, IDO1, KDR, MET, MMP9, PIM1, PPARG, PRKCA, PRKCB, PRKCE, SRC |
2.30187 |
[BP] GO:0044093 |
positive regulation of molecular function
|
AR, AURKB, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, MET, MMP9, PPARG, PRKCB, PRKCD, PRKCE, SRC, XDH |
2.30116 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
CSNK2A1, PRKCA, PRKCB, PRKCD |
2.26249 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
AR, AURKB, CSNK2A1, ESR1, ESR2, FABP4, HSP90AB1, IGF1R, KDR, MMP9, NR3C1, PGR, PPARG, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
2.24753 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, AR, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PRKCA, PRKCD, PRKCE, PRKCG, SRC, XDH |
2.23407 |
[BP] GO:0070542 |
None
|
FABP3, PPARG, PRKCE, SRC |
2.22593 |
[BP] GO:0032800 |
receptor biosynthetic process
|
ACHE, PPARG |
2.21534 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AR, AURKB, ESR1, ESR2, FABP3, HSP90AA1, HSP90AB1, IGF1R, MET, NR3C1, PGR, PPARG, PRKCD, RORC, SRC |
2.21534 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, AR, FLT3, HSP90AB1, KDR, MMP9, PRKCA, PRKCD, PRKCE, SRC, XDH |
2.2097 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, ALOX15, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, HSP90AA1, HSP90AB1, IDO1, MMP2, MMP9, PPARG, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
2.20459 |
[BP] GO:0035265 |
organ growth
|
AR, CYP19A1, ESR1 |
2.20266 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, AR, FLT3, KDR, PRKCA, PRKCE, SRC, XDH |
2.19669 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, PPARG, TYR |
2.19669 |
[BP] GO:2000145 |
regulation of cell motility
|
CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARG, PRKCA, PRKCE, SRC |
2.19029 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, AR, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PRKCA, PRKCD, PRKCE, SRC, XDH |
2.18016 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, IDO1, XDH |
2.16523 |
[BP] GO:0051172 |
None
|
AR, AURKB, CSNK2A1, ESR1, ESR2, FABP4, HSP90AB1, IGF1R, MMP9, NR3C1, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
2.15499 |
[BP] GO:0002684 |
positive regulation of immune system process
|
AXL, CA2, HSP90AA1, HSP90AB1, IDO1, MMP2, PRKCA, PRKCB, PRKCD, PRKCE, SRC |
2.15156 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
CSNK2A1, PRKCA, PRKCB, PRKCD |
2.14661 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
2.13439 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
AR, CYP1B1, ESR1, ESR2, PIM1, PPARG, PRKCB |
2.12943 |
[BP] GO:0045321 |
leukocyte activation
|
ALOX5, AXL, FLT3, HSP90AA1, HSP90AB1, MMP9, PRKCB, PRKCD, PRKCE, RORC |
2.12636 |
[BP] GO:0050776 |
regulation of immune response
|
ALOX15, ESR1, HSP90AA1, HSP90AB1, IDO1, MMP2, PPARG, PRKCB, PRKCD, PRKCE, SRC |
2.09991 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, HSP90AA1, HSP90AB1, PRKCD, XDH |
2.09313 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, AR, CSNK2A1, ESR1, FLT3, HSP90AB1, KDR, MMP9, PPARG, PRKCA, PRKCD, PRKCE, SRC, XDH |
2.09313 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.07403 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
HSP90AA1, HSP90AB1, PRKCD, XDH |
2.06671 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.06671 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, SRC |
2.06058 |
[BP] GO:0043279 |
None
|
HSP90AB1, PPARG, PRKCE, PRKCG |
2.0537 |
[BP] GO:0009058 |
None
|
ACHE, AKR1B1, ALOX15, ALOX5, AR, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IDO1, NR3C1, NR3C2, PGR, PPARG, PRKCB, RORC, TYR |
2.04825 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, AXL, CA2, CA7, CYP19A1, HSP90AB1, MMP9, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
2.04825 |
[BP] GO:0001890 |
placenta development
|
HSD17B2, HSP90AB1, PPARG |
2.0401 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, ESR1, MET, SRC |
2.0268 |
[BP] GO:0051973 |
positive regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1 |
2.00745 |
[BP] GO:0044087 |
regulation of cellular component biogenesis
|
ALOX15, ESR1, HSP90AA1, KDR, MET, MMP1, PRKCA, PRKCD, PRKCE, SRC |
2.00322 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ALOX15, AR, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
2.00025 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, ALOX15, ALOX5, AR, AURKB, CA1, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, IDO1, KDR, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TYR, XDH |
3.82036 |
[CC] GO:0005829 |
cytosol
|
AKR1B1, ALOX15, ALOX5, AR, AURKB, CA1, CA2, CA7, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IDO1, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TYR, XDH |
2.96234 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX15, ALOX5, ALPL, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FLT3, HSD11B1, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, NR3C2, PGR, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TYR |
2.95684 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, CA4, PPARG, PRKCA, PRKCD, PRKCE, PRKCG, SRC, TYR |
2.92037 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ALOX15, ALPL, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, ESR1, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
2.0268 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCG, RORC, TYR, XDH |
21.6704 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TYR, XDH |
17.4988 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
13.126 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARG, PRKCA, PRKCB, PRKCG, RORC |
11.3641 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, IDO1, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, TYR, XDH |
11.0192 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, IDO1, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, TYR, XDH |
10.4954 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FLT3, HSD11B1, HSD17B1, HSD17B2, HSP90AA1, IDO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TYR, XDH |
9.58877 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.51425 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, NR3C1, NR3C2, PGR, PPARG, RORC |
8.30588 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.48281 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
7.32345 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
7.14437 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, HSD17B1, NR3C1, NR3C2, PGR, RORC |
7.10446 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
6.82813 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
6.4532 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
6.43832 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD11B1, HSD17B1, HSD17B2, IDO1, TYR, XDH |
6.31284 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.98034 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, SRC |
5.98034 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, SRC |
5.77991 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, PGR, PPARG, RORC |
5.77991 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, PGR, PPARG, RORC |
5.77991 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.77991 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.56809 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
5.56341 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARG, RORC |
5.0483 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, PRKCD, SRC |
4.9954 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
4.94539 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.72986 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.69034 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.43969 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.28361 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
ESR1, HSP90AA1, HSP90AB1 |
3.8762 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, IDO1, SRC, XDH |
3.85787 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.84701 |
[MF] GO:0036094 |
small molecule binding
|
AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, XDH |
3.77815 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, XDH |
3.6348 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
3.59534 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
3.48297 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.46572 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
3.46572 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.42395 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
3.34864 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1 |
3.2899 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
3.23509 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, PPARG, PRKCB, SRC |
3.22217 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.03486 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.03486 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
3.03486 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, XDH |
2.98078 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, XDH |
2.98027 |
[MF] GO:1901363 |
heterocyclic compound binding
|
AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
2.93427 |
[MF] GO:0097159 |
organic cyclic compound binding
|
AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IDO1, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PIM1, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, XDH |
2.89354 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, IDO1, XDH |
2.8563 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, PRKCA, PRKCB |
2.82979 |
[MF] GO:0019899 |
enzyme binding
|
AR, AURKB, CYP1A1, CYP1A2, CYP2A6, ESR1, ESR2, HSP90AA1, HSP90AB1, MET, NR3C1, PGR, PPARG, PRKCA, PRKCB, PRKCD, PRKCE, SRC |
2.78888 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
2.63043 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.62922 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, CSNK2A1, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PGR, PPARG, TYR, XDH |
2.56763 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
2.52249 |
[MF] GO:0017076 |
purine nucleotide binding
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
2.49971 |
[MF] GO:0032553 |
ribonucleotide binding
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
2.49443 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CSNK2A1, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
2.47903 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, HSD11B1, HSD17B1, HSD17B2, XDH |
2.44361 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
2.40196 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.38798 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1 |
2.34806 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARG |
2.31764 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.31764 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1 |
2.31764 |
[MF] GO:0035257 |
None
|
ESR1, FLT3, PPARG, PRKCB, SRC |
2.31764 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.23478 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.21534 |
[MF] GO:0038023 |
signaling receptor activity
|
AR, AXL, ESR1, ESR2, FLT3, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARG, RORC |
2.19631 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.13439 |
[MF] GO:0050543 |
None
|
FABP3, PPARG |
2.07403 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.07403 |
[MF] GO:0051427 |
hormone receptor binding
|
ESR1, FLT3, PPARG, PRKCB, SRC |
2.06671 |